Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers explore how protein production gets distorted in skin cancer

30.01.2017

Each cell in the body follows a strict protocol for manufacturing the proteins it needs to function. When a cell turns cancerous, however, its protein production goes off script. A new study led by researchers at The Rockefeller University takes a close look at one way in which this procedure goes haywire in skin cells as they turn cancerous.

"A cell's identity depends on the levels of proteins it produces, and these can be altered by changes in the way proteins are translated from genetic instructions," says senior author Elaine Fuchs, the Rebecca C. Lancefield Professor and head of the Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development.


To examine how the production of protein can shift as cells become malignant, the researchers first primed mouse skin to express a molecule (green) common in tumors.

Credit: Laboratory of Mammalian Cell Biology at The Rockefeller University/Nature

"Changes in translation appear to be particularly important as normal stem cells become malignant, and our new experiments detail the control mechanisms behind a shift that occurs just prior to the development of skin cancer," adds Fuchs, who is a Howard Hughes Medical Institute investigator. The research, which identifies a potential avenue for future cancer treatments, was described in Nature on January 11.

In order to function, cells need to turn instructions encoded in their DNA into protein. They do so in two major steps: first, DNA is transcribed into a molecule called messenger RNA, which is then translated into protein. Certain cancerous tumors are known to contain an unusual ratio of protein to messenger RNA, however, which suggests translation is altered in cancer.

Using mice, the team explored changes in translation that occur as the animals develop a common type of skin cancer called squamous cell carcinoma. Adapting a technique developed for cultured cells in co-author Jonathan Weissman's lab at the University of California, San Francisco, they captured messenger RNA as it was being translated within skin stem cells in mice. These molecules were collected from both normal skin stem cells and those primed to become malignant.

Within the pre-malignant cells, the researchers found decreases in regular protein production as well as an uptick in tumor-promoting proteins. Ataman Sendoel, a postdoc in the Fuchs lab and first author on the study, traced this shift back to a change in the proteins that kick off the process of translation. In regular skin cells, eIF2 has this job; in the soon-to-be cancerous cells, he found that eIF2 was inactivated, and its relative, eIF2A, had taken over.

Next, the researchers looked for evidence that eIF2A has a similar role in humans. By searching the publicly available Cancer Genome Atlas, which contains genetic data from 11,000 patients, they found extra copies of the gene encoding eIF2A in 29 percent of patients with squamous cell carcinomas in the lungs, and in 15 percent of those with tumors in the head or neck. Moreover, patients in whose cells the gene was more active had a poorer prognosis, surviving and remaining disease-free for less time compared to those with normal eIF2A activity.

The team's work suggests eIF2A could potentially provide a therapeutic target for new cancer treatments, and the researchers have begun investigating this possibility with help from a grant from the Robertson Therapeutic Development Fund.

"By looking for molecular inhibitors that can turn off eIF2A--and, as a result the translation of cancer-associated proteins--we suspect it may be possible to stop the formation of new tumors," says Sendoel. "For instance, one could envision using such a treatment after tumor surgery to inhibit any tumor-initiating cells that remain."

Media Contact

Katherine Fenz
kfenz@rockefeller.edu
212-327-7913

 @rockefelleruniv

http://www.rockefeller.edu 

Katherine Fenz | EurekAlert!

More articles from Health and Medicine:

nachricht Preventing metastasis by stopping cancer cells from making fat
23.01.2020 | Université catholique de Louvain

nachricht Possible Alzheimer's breakthrough suggested
22.01.2020 | Case Western Reserve University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Integrate Micro Chips for electronic Skin

Researchers from Dresden and Osaka present the first fully integrated flexible electronics made of magnetic sensors and organic circuits which opens the path towards the development of electronic skin.

Human skin is a fascinating and multifunctional organ with unique properties originating from its flexible and compliant nature. It allows for interfacing with...

Im Focus: Dresden researchers discover resistance mechanism in aggressive cancer

Protease blocks guardian function against uncontrolled cell division

Researchers of the Carl Gustav Carus University Hospital Dresden at the National Center for Tumor Diseases Dresden (NCT/UCC), together with an international...

Im Focus: New roles found for Huntington's disease protein

Crucial role in synapse formation could be new avenue toward treatment

A Duke University research team has identified a new function of a gene called huntingtin, a mutation of which underlies the progressive neurodegenerative...

Im Focus: A new look at 'strange metals'

For years, a new synthesis method has been developed at TU Wien (Vienna) to unlock the secrets of "strange metals". Now a breakthrough has been achieved. The results have been published in "Science".

Superconductors allow electrical current to flow without any resistance - but only below a certain critical temperature. Many materials have to be cooled down...

Im Focus: Programmable nests for cells

KIT researchers develop novel composites of DNA, silica particles, and carbon nanotubes -- Properties can be tailored to various applications

Using DNA, smallest silica particles, and carbon nanotubes, researchers of Karlsruhe Institute of Technology (KIT) developed novel programmable materials....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

 
Latest News

Physicists trap light in nanoresonators for record time

23.01.2020 | Physics and Astronomy

The easy route the easy way: New chip calculates the shortest distance in an instant

23.01.2020 | Information Technology

DYNAFLEX® at e-World 2020

23.01.2020 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>